RecruitingNot ApplicableNCT05622344

StableEyes With Active Neurofeedback

StableEyes With Active Neurophysiological Feedback


Sponsor

Johns Hopkins University

Enrollment

48 participants

Start Date

Aug 8, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.


Eligibility

Min Age: 21 YearsMax Age: 70 Years

Inclusion Criteria4

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma
  • Willing to adhere to the SWAN and/or vestibular rehabilitation regimen

Exclusion Criteria5

  • Current use of anti-nausea medication
  • Presence of cervical spine pathology that limits head motion to \< 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis)
  • Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery)
  • Legal blindness (20/200 or worse visual acuity)
  • Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTraditional Therapy

Exercises that teaches subjects to move their heads while viewing still or moving targets.

DEVICESWAN

The SWAN device uses video-oculography to monitor head motion while guiding participants to move their head in yaw, pitch, roll planes for 15 minutes. Feedback is provided regarding frequency and plane of head rotation


Locations(2)

Johns Hopkins University

Baltimore, Maryland, United States

Naval Medical Research Unit

Dayton, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05622344


Related Trials